Invion (ASX:IVX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invion.
RELATED STOCKHEAD STORIES
Health Check: Aroa’s ‘hero’ product propels the wound management house back into black
Lunch Wrap: ASX up as Trump tariffs tossed by court, Nvidia fuels data centre rally
Top 10 at 11: ASX lifts 0.2pc against global market falls
Break it Down: Invion completes six patient dosings in cancer trial
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million
Health Check: Biotech’s forgotten tortoises pick up the pace as sector emerges from two-year slump
ASX Lunch Wrap: ASX takes historic leap to 8500 level; Zip co-founder Larry Diamond exits
Health Check: Let there be light (therapy). Invion up 160pc on skin cancer trial news
Biocurious: Invion taps the power of light to zap solid tumours
Top 10 at 11: A real mixed bag to kick off the winner’s list for today
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: ASX hits record, Nanoveu doubles on AI news, Tyro drops 10pc on new debit card proposal
